MINTEZOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mintezol, and what generic alternatives are available?
Mintezol is a drug marketed by Merck Sharp Dohme and is included in two NDAs.
The generic ingredient in MINTEZOL is thiabendazole. There is one drug master file entry for this compound. Additional details are available on the thiabendazole profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MINTEZOL?
- What are the global sales for MINTEZOL?
- What is Average Wholesale Price for MINTEZOL?
Summary for MINTEZOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 144 |
| Patent Applications: | 3,254 |
| DailyMed Link: | MINTEZOL at DailyMed |
US Patents and Regulatory Information for MINTEZOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck Sharp Dohme | MINTEZOL | thiabendazole | SUSPENSION;ORAL | 016097-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck Sharp Dohme | MINTEZOL | thiabendazole | TABLET, CHEWABLE;ORAL | 016096-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
